tiprankstipranks
SMS Pharmaceuticals Ensures Compliance with SEBI Regulations
Company Announcements

SMS Pharmaceuticals Ensures Compliance with SEBI Regulations

Story Highlights

Maximize Your Portfolio with Data Driven Insights:

  • Leverage the power of TipRanks' Smart Score, a data-driven tool to help you uncover top performing stocks and make informed investment decisions.
  • Monitor your stock picks and compare them to top Wall Street Analysts' recommendations with Your Smart Portfolio

An announcement from SMS Pharmaceuticals Limited ( (IN:SMSPHARMA) ) is now available.

SMS Pharmaceuticals Limited has announced that it has complied with Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, for the quarter ending December 31, 2024. This compliance highlights the company’s adherence to regulatory standards, which is crucial for maintaining its market credibility and ensuring seamless operations for stakeholders.

More about SMS Pharmaceuticals Limited

SMS Pharmaceuticals Limited operates within the pharmaceutical industry, focusing on the production of active pharmaceutical ingredients (APIs) and intermediates. The company is known for its commitment to quality and compliance, catering to both domestic and international markets.

YTD Price Performance: -13.89%

Average Trading Volume: 17,054

Current Market Cap: 18.81B INR

See more data about SMSPHARMA stock on TipRanks’ Stock Analysis page.

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App